Abstract
To determine why nonionic, low-osmolality contrast media (LOCM) at high concentrations (> 30%) induce almost immediate platelet activation and to explore preventive measures. Nonionic LOCM, when added to blood, activates platelets, raises the osmolality, and lowers the ionic strength. To clarify the mechanisms involved, platelet activation was studied in sodium chloride-sucrose solutions of varying osmolalities and varying ionic strengths. Several salts and Iloprost were evaluated as potential inhibitors of platelet activation. Platelets are activated by both osmolality and ionic strength changes. The salts most inhibitory to platelet activation were magnesium sulfate and sodium citrate. Iloprost lowered platelet activation to control levels at 4.3 ng/mL of nonionic LOCM and completely eliminated it at 8.6 ng/mL. Three-quarters of nonionic LOCM-induced platelet activation appeared to be due to increased osmolality-the remainder to the decrease in ionic strength. Magnesium sulfate and Iloprost are potent inhibitors of this type of platelet activation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
